recurrent selection

Show results for

Unknown (1555)
Transcriptomics (311)
Genomics (236)
Proteomics (34)
Metabolomics (14)
Clinical (6)
Other (5)
Methylation profiling (4)
Genomic (3)
Models (1)

Organisms

Homo sapiens (282)
Mus musculus (47)
Saccharomyces cerevisiae (17)
Drosophila melanogaster (11)
Arabidopsis thaliana (5)
Burkholderia multivorans (2)
Zea mays (2)
Streptococcus pneumoniae (2)
Bathyergus suillus (1)
Tremella fuciformis (1)
Spodoptera exigua (1)
Saccharomyces cerevisiae BY4741 (1)
Mesorhizobium metallidurans STM 2683 (1)
Salvelinus fontinalis (1)
Saccharomyces paradoxus (1)
Mustela putorius furo (1)
Populus tremuloides (1)
Pan troglodytes (1)
Plasmodium berghei (1)
Schizosaccharomyces pombe (1)
Salmonella enterica subsp. enterica serovar Typhimurium str. SL1344 (1)
Staphylococcus aureus (1)
Hordeum vulgare (1)
Pseudomonas putida (1)
Bos taurus (1)
Triticum aestivum (1)
Canis lupus familiaris (1)
Pseudomonas aeruginosa (1)
Escherichia coli (1)
Rattus norvegicus (1)

Organisms

Homo sapiens (75)
Mus musculus (10)
Arabidopsis thaliana (4)
Abies pinsapo (1)
Crassostrea virginica (1)
Papio anubis (1)
Streptococcus pneumoniae (1)
Macaca mulatta (1)
Hordeum vulgare (1)
Acinetobacter baumannii (1)
Glycine max (1)
Plasmodium falciparum (1)

Repository

biostudies-arrayexpress (294)
ENA (167)
geo (53)
EGA (42)
pride (29)
MetaboLights (14)
MassIVE (4)
dbGaP (3)
BioModels (1)
PanoramaPublic (1)

Tissue

Cell culture (8)
Blood (4)
Blood plasma (3)
Epithelial cell (3)
Primary cell (2)
B cell (1)
Breast (1)
Breast cancer cell line (1)
Bronchoalveolar lavage (1)
Cardiac muscle cell (1)
Cell suspension culture (1)
Colon (1)
Eye (1)
Head and neck squamous cell carcinoma cell line (1)
Heart (1)
Hypothalamus (1)
Leukocyte (1)
Macrophage (1)
Mammary gland tumor cell (1)
Monocyte (1)
Osteocyte (1)
Permanent cell line cell (1)
Primary cell line cell (1)
Skin (1)
Tissue (1)

Disease

Wilms tumour (3)
Normal (3)
Glioblastoma (2)
Colorectal cancer (2)
Lymphoma (2)
High grade glioblastoma (1)
Chronic lymphocytic leukemia (CLL) (1)
Extranodal NK/T-Cell Lymphoma derived cell line (1)
Pancreatic ductal adenocarcinoma (1)
Liposarcoma (1)
Cancer cell line pool (1)
Osteosarcoma (1)
Adenoid cystic carcinoma (1)
Leiomyosarcoma (1)
Non-small cell lung carcinoma (1)
Prostate cancer (1)
Ovarian cancer (1)
Central nervous system cancer (1)
Cervical cancer (1)
Recurrent Rectal Cancer (1)
All cancers located in pelvic region treated with radiation therapy (1)
Locally advanced pelvic malignancy (1)
Colorectal Neoplasms (1)
Neoplasms (1)
Asthma (1)
Autoimmune disease of blood (1)
Breast cancer (1)
Bronchiolitis obliterans (1)
Cervix carcinoma (1)
Chronic lymphocytic leukemia (1)

Technology Type

Mass Spectrometry (29)
Shotgun proteomics (15)
Mass spectrometry (11)
Bottom-up proteomics (6)
Illumina HiSeq 2000 (5)
Data-dependent acquisition (4)
Affinity purification coupled with mass spectrometry proteomics (3)
SWATH MS (3)
Mass spectrometry assay (2)
Gel-based experiment (2)
Illumina 450K (1)
ILLUMINA, Illumina HiSeq 2500, Illumina HiSeq 2000 (1)
Illumina HiSeq 2500 (ILLUMINA), AB SOLiD System (ABI_SOLID) (1)
NMR spectroscopy assay (1)
Data-independent acquisition (1)
SRM/MRM (1)

Instrument Platform

Illumina NovaSeq 6000 (6)
Q Exactive (6)
Illumina HiSeq 2000 (5)
NextSeq 500 (3)
Liquid Chromatography MS - negative - reverse phase (3)
Liquid Chromatography MS - positive - reverse phase (3)
Agilent G2565BA (2)
Orbitrap Fusion Lumos (2)
Liquid Chromatography MS - positive - reverse-phase (2)
Liquid Chromatography MS - negative - reverse-phase (2)
Chromium Controller with Chromium Next GEM Single Cell 5’ and V(D)J (kits v1.1) (1)
Chromium Controller (1)
PromethION (1)
G2565BA DNA microarray scanner (1)
Qiagen MinElute (1)
Not applicable (1)
Illumina Hiseq 2000 (1)
NextSeq 1000 (1)
NextSeq 2000 (1)
Illumina MiSeq (1)
NextSeq 550 (1)
Illumina HiSeq 2500 (1)
Illumina HiSeq 4000 (1)
Orbitrap Eclipse (1)
Orbitrap Fusion (1)
Q Exactive Plus (1)
Liquid Chromatography MS - - - Q Exactive (1)
Nuclear Magnetic Resonance (NMR) - (1)

Publication Date

2010 (48)
2015 (43)
2013 (41)
2011 (41)
2012 (27)
2016 (21)
2014 (19)
2021 (17)
2023 (16)
2025 (16)
2008 (15)
2026 (14)
2024 (14)
2022 (14)
2009 (14)
2017 (11)
2007 (8)
2020 (4)
2019 (4)
2018 (3)
2006 (3)
2005 (2)

CHEBI ID

CHEBI:17596 (7)
CHEBI:17768 (6)
CHEBI:40410 (6)
CHEBI:15676 (6)
CHEBI:16708 (6)
CHEBI:17113 (6)
CHEBI:17754 (6)
CHEBI:16610 (6)
CHEBI:16566 (6)
CHEBI:16393 (6)
CHEBI:82914 (6)
CHEBI:16704 (6)
CHEBI:15891 (6)
CHEBI:16958 (6)
CHEBI:18132 (6)
CHEBI:17568 (6)
CHEBI:17802 (6)
CHEBI:16750 (6)
CHEBI:15428 (6)
CHEBI:17154 (6)
CHEBI:16737 (6)
CHEBI:16919 (6)
CHEBI:15724 (6)
CHEBI:15354 (6)
CHEBI:17368 (6)
CHEBI:90344 (5)
CHEBI:16974 (5)
CHEBI:132948 (5)
CHEBI:45441 (5)
CHEBI:21626 (5)

Metabolite Name

N-acetylhistidine (7)
Hypoxanthine (7)
Trimethylamine N-oxide (6)
Sphingosine (6)
Sphinganine (6)
Pyridoxate (6)
N-formylmethionine (6)
N-acetylputrescine (6)
N-acetylphenylalanine (6)
Erythritol (6)
Ribose (6)
5-oxoproline (6)
Uridine (6)
Tryptophan (6)
Taurine (6)
Serine (6)
Pseudouridine (6)
Proline (6)
Nicotinamide (6)
Lysine (6)
Inosine (6)
Guanosine (6)
Glycerophosphoethanolamine (6)
Citrulline (6)
Carnitine (6)
Asparagine (6)
Arginine (6)
Allantoin (6)
Adenine (6)
Histidine (6)

First Public Date

2026 (25)
2021 (20)
2025 (19)
2014 (19)
2015 (16)
2024 (12)
2023 (12)
2020 (12)
2022 (11)
2018 (5)
2017 (5)
2019 (4)
2016 (3)
2013 (3)
2011 (1)

Modelling Approach

Computational model (1)

Study status

Recruiting (2)
Active, not recruiting (1)
Not provided (1)
Not yet recruiting (1)
Completed (1)

Lab affiliation

1Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA. 2Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA. 3Biological and Biomedical Sciences Program, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. (1)
2. Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK (1)
Associate Professor in Molecular Reproductive Biology, Discovery and Translational Sciences Department, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), Faculty of Medicine and Health Sciences, University of Leeds, UK (1)
Biomolecular characterization unit, Center for Sustainable Resource Science, RIKEN (1)
Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, NE2 4HH, United Kingdom (1)
CRUK Scotland Institute for Cancer Research - Switchback Rd, Bearsden, Glasgow G61 1BD - United Kingdom (1)
Center for Integraive Genomics (CIG), University of Lausanne, 1015 Lausanne, Switzerland (1)
Centre of Biological Engineering (CEB), University of Minho, Braga, Portugal (1)
Chronic Disease Programme (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain (1)
Department of Convergence Medicine, Convergence Medicine Research Center/Biomedical Research Center, Asan Medical Center, Asan Institute for Life Sciences, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea. (1)
Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA;Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO, USA;McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA (1)
Department of Genome Sciences, University of Washington, Seattle, WA, USA (1)
Department of Molecular Cell Biology The Weizmann Institute of Science Rehovot, Israel (1)
Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany (1)
Epigenetics and Cell Fate Centre CNRS UMR7216 – Université Paris Cité Lamarck B building, 4th floor, room 413 35, rue Hélène Brion 75205 Paris Cedex 13 +33157278981 (1)
Head of the Department, Proteomics Core (1)
IRCCS IST. G. Gaslini (1)
Laboratory Pathogenesis of Bacterial Anaerobes (LPBA) Institut Pasteur 25, rue du Docteur Roux 75015 PARIS (1)
Leiden University Medical Center, Center for Proteomics and Metabolomics, PO Box 9600, Postal zone P1-Q, 2300 RC Leiden, The Netherlands (1)
Luxembourg Institute of Science and Technology “Environmental Research and Innovation” (ERIN) department 41, rue du Brill, L-4422 Belvaux LUXEMBOURG Tel +tel: +352 275 888- 860 Fax +352 275 885 (1)
Michael Smith Laboratories, Biochemistry and Molecular Biology, University of British Columbia, Canada (1)
Molecular Therapy of Virus-Associated Cancers, German Cancer Research Center (DKFZ), Heidelberg, Germany. (1)
Normandie Univ, INSERM U1245, UNICAEN, Caen, France (1)
Paris Cardiovascular Research Center (PARCC); INSERM UMR970; Université Paris Descartes; Paris, France (1)
Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands (1)
Univeristy of California San Francisco (UCSF), Department of Bioengineering and Therapeutic Sciences, USA, San Francisco (1)
University of Victoria, Department of Mechanical Engineering, PO Box 1700 STN CSC, Victoria, BC, V8W 2Y2, Canada (1)
Zhengzhou University (1)
i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Portugal Serviço de Microbiologia, Departamento de Ciências Biológicas, Faculdade de Farmácia da Universidade do Porto, Portugal (1)

Keyword

Virtual Reality (1)
VR (1)
GI cancer (1)
Support (1)

IsPrivate

False (1)

Submitter Keywords

FAIR-AIML (1)
Machine Learning Model (1)

Classification

bacteria (2)
protozoa (1)

Study type

Transcription profiling by array (118)
Comparative genomic hybridization by array (59)
RNA-seq of coding RNA (47)
Unknown experiment type (12)
ChIP-seq (8)
Methylation profiling by array (7)
RNA-seq of coding RNA from single cells (6)
ChIP-chip by tiling array (5)
Genotyping by array (5)
Other (5)
Observational (5)
Methylation profiling by high throughput sequencing (4)
RNA-seq of non coding RNA (4)
ChIP-chip by array (3)
DNA-seq (3)
RNA-seq of non coding RNA from single cells (1)
Human - High-throughput sequencing (1)
Animal - High-throughput sequencing (1)
Transcription profiling by tiling array (1)
Transcription profiling by RT-PCR (1)
ATAC-seq (1)
MicroRNA profiling by array (1)
RNA-seq of total RNA (1)
Interventional (1)

Release Date

2025 (200)
2022 (179)
2023 (173)
2021 (167)
2024 (116)
2020 (116)
2019 (107)
2018 (97)
2015 (90)
2017 (89)
2016 (80)
2014 (68)
2013 (64)
2010 (60)
2012 (56)
2011 (56)
2026 (35)
2009 (28)
2008 (22)
2007 (18)
2006 (9)
2005 (9)
2000 (2)
1999 (2)
2004 (1)
2003 (1)
2002 (1)
2001 (1)
1997 (1)

Location

Australia (4)
France (2)
India (1)
New Zealand (1)
Norway (1)
Taiwan (1)
United Kingdom (1)
Japan (1)
Italy (1)
Canada (1)
Germany (1)
United States (1)

Previous page
1 / 217
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 217
Next page

Sort by:

Relevance

Page size

Serum Metabolomics in the Rat Model of Recurrent Pelvic Pain

This study aimed to investigate systemic metabolic alterations underlying pain-depression comorbidity in the Recurrent Pelvic Pain (RPP) rat model using untargeted serum metabolomics (UPLC-Q-Orbitrap-MS). Comparative analysis revealed distinct metabolic profiles, identifying 234 differential meta...

2026-02-11 | MTBLS13869 | MetaboLights

Untargeted Plasma Lipidomics Identifies Oxidative Stress and Inflammation Signatures Associated with Recurrent Leg Ulcer Status in Sickle Cell Disease

Leg ulcers are among the most burdensome complications of sickle cell disease (SCD), yet the molecular determinants underlying ulcer susceptibility and recurrence remain incompletely characterized. We performed untargeted plasma lipidomics by LC–MS in 129 individuals with SCD from the REDS-III Br...

2025-12-19 | MTBLS13538 | MetaboLights

Intrathymic T-cell selection

Comparisons between untreated primary cells T-cell precursors from the thymus. CD69- thymocytes are from Zap70-deficent mice and are >95% CD4+CD8+. These cells fail to generate intrathymic TCR signals as a result of their lacking Zap70 molecules, and are thus representative of "preselection" CD4+CD8...

ORGANISM(S): Mus musculus

2010-06-10 | E-GEOD-2262 | biostudies-arrayexpress

Recurrent 15q13 microdeletions

We report a recurrent microdeletion syndrome causing mental retardation, epilepsy and variable facial and digital dysmorphisms. We describe nine patients, including six probands; two with de novo deletions, two who inherited the deletion from an affected parent, and two with unknown inheritance. The...

ORGANISM(S): Homo sapiens

2010-05-26 | E-GEOD-10189 | biostudies-arrayexpress

Quality control of transcription start site selection by Nonsense-Mediated-mRNA Decay

Nonsense-mediated mRNA decay (NMD) is a translation-dependent RNA quality-control pathway targeting transcripts such as messenger RNAs harboring premature stop-codons or short upstream open reading frame (uORFs). Our transcription start sites (TSSs) analysis of Saccharomyces cerevisiae cells deficie...

ORGANISM(S): Saccharomyces cerevisiae BY4741

2015-04-24 | E-GEOD-64139 | biostudies-arrayexpress

Is there an advantage of using genomic information to estimate gametic variances and improve recurrent selection in animal populations?

Not available

S-EPMC11831845 | biostudies-literature

Micro RNA expression from human hepatocellular carcinoma (HCC) specimens from patients undergoing liver transplantation.

Current selection criteria for liver transplant in patients with HCC (the Milan criteria) do not incorporate biologic metrics. MiRNA expression profiles correlate with HCC recurrence after transplant and can add significant value to the Milan criteria. MiRNA expression profiles were studied in HCC s...

ORGANISM(S): Homo sapiens

2011-10-14 | E-GEOD-30297 | biostudies-arrayexpress

Post-Liver Transplant Recurrent Human Hepatocellular Carcinoma Study (RHCCS)

The whole exome sequencing showed that HERC5 deletion and under-expression associates with shorter: time to tumor recurrence, progression-free, and overall survival in hepatocellular carcinoma (HCC) in two independent studies (p1=0.004, HR1=1.80; p2=0.018, HR2=3.31) totaling 286 HCC patients. Mat...

phs000782 | dbGaP

A proteome analysis of freezing tolerance in red clover (Trifolium pratense L.)

Improvement of freezing tolerance of red clover (Trifolium pratense L.) would increase its persistence under cold climate. In this study, we assessed the freezing tolerance and compared the proteome composition of non-acclimated and cold-acclimated plants of two initial cultivars of red clover: Endu...

ORGANISM(S): Trifolium pratense subsp. pratense

2016-03-15 | PXD003689 | Pride

Optimal cross selection for long-term genetic gain in two-part programs with rapid recurrent genomic selection.

Not available

S-EPMC6096640 | biostudies-literature

Previous page
1 / 217
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 217
Next page

Sort by:

Relevance

Page size

2169 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Modelling Approach

Study status

Lab affiliation

Tags

Keyword

IsPrivate

Submitter Keywords

Classification

Study type

Release Date

Location

OmicsDI is part of the ELIXIR infrastructure

Tweets